Skip to main content
. 2021 Jun 21;12(6):948. doi: 10.3390/genes12060948

Figure 5.

Figure 5

Administration AAV-DIO-αSyn to nigra induced bradykinesia in DAT-Cre rats. (A) Timeline of experiment. Animals receiving AAV-DIO-αSyn or AAV-mChery were placed in infrared locomotor activity chambers for 12 h (7 p.m. to 7 a.m.) during the dark cycle. (B) Intranigral administration of AAV-DIO-αSyn significantly reduced HACTV, TOTDIST, MOVNO, MOVTIME, and VACTV, while increased RESTIME. * Significant difference determined by t-test.